US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

23.79

-0.1500-0.63%

Volume:2.18M

Turnover:52.36M

Market Cap:2.67B

PE:-23.59

High:24.68

Open:23.81

Low:23.30

Close:23.94

Loading ...

Overview Company News Filings

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Shares of Some Obesity Drug Developers Fall After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS

U.S.-Listed Shares of Novo Nordisk Down 7.9%, Viking Therapeutics Down 3.9%, Amgen Down 3.4%

THOMSON REUTERS

Lilly's Weight-Loss Pill Shocks Wall Street

BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial

Eli Lilly's stock soars as successful trial of weight-loss pill is a game changer

Shares of Obesity Drug Developer Viking Therapeutics Falls 5.3% Premarket After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?

Viking Therapeutics’ VK2735: A Promising Contender Amidst Pfizer’s Setback

Promising Pipeline and Strategic Developments Drive Buy Rating for Viking Therapeutics

Pfizer Halts Obesity Pill Development Amid Safety Concerns

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VKTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VKTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VKTX\",,,,,undefined,":{"symbol":"VKTX","market":"US","secType":"STK","nameCN":"Viking Therapeutics","latestPrice":23.79,"timestamp":1745264013189,"preClose":23.94,"halted":0,"volume":2181817,"delay":0,"floatShares":109743358,"shares":112247809,"eps":-1.008491,"marketStatus":"Trading","change":-0.15,"latestTime":"04-21 15:33:36 EDT","open":23.81,"high":24.6827,"low":23.3,"amount":52355456.731688,"amplitude":0.057757,"askPrice":23.8,"askSize":10,"bidPrice":23.78,"bidSize":284,"shortable":0,"etf":0,"ttmEps":-1.008491,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1430280000000,"exchange":"NASDAQ","adjPreClose":23.94,"preHourTrading":{"tag":"盘前","latestPrice":23.82,"preClose":23.94,"latestTime":"09:28 EDT","volume":20866,"amount":490642.01810200006,"timestamp":1745242090097},"postHourTrading":{"tag":"盘后","latestPrice":23.99,"preClose":23.94,"latestTime":"19:59 EDT","volume":37815,"amount":905931.2901,"timestamp":1744934349897},"volumeRatio":0.479209,"impliedVol":0.9867,"impliedVolPercentile":0.664},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VKTX\",,,,,undefined,":{"symbol":"VKTX","floatShares":109743358,"roa":"-14.78%","roe":"-17.90%","lyrEps":-1.008491,"volumeRatio":0.479209,"shares":112247809,"dividePrice":0,"high":24.6827,"amplitude":0.057757,"preClose":23.94,"low":23.3,"week52Low":18.92,"pbRate":"3.03","week52High":81.86,"institutionHeld":0,"latestPrice":23.79,"committee":0.931973,"eps":-1.008491,"divideRate":0,"volume":2181817,"delay":0,"ttmEps":-1.008491,"open":23.81,"prevYearClose":40.24,"prevWeekClose":23.94,"prevMonthClose":24.15,"prevQuarterClose":24.15,"fiveDayClose":22.22,"twentyDayClose":28.95,"sixtyDayClose":34.94,"earningDate":1745337600000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VKTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529138887","title":"LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2529138887","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529138887?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:37","pubTimestamp":1745239020,"startTime":"0","endTime":"0","summary":"Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the primary goal of significantly reducing A1C levels compared to placebo at 40 weeks, with an average A1C reduction of 1.3% to 1.6% from a baseline of 8%. LLY’s orforglipron is an investigational, once-daily small-molecule oral GLP-1 receptor agonist that can be administered at any time of the day without restrictions on food and water intake.The phase III ACHIEVE-1 study, the first of sevenlate-stage studies, is evaluating the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes  and inadequate glycemic control with diet and exercise alone. The enrolled patients in the 40-week study were randomized equally to receive either a 3 mg, 12 mg or 36 mg dose of orforglipron or placebo. Lilly is also developing a version of this oral drug for obesity.Year to date, shares of Lilly have gained 8.8% against the industry’s 3.3% decline.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lly-stock-oral-glp-1-123700472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","LU0640476718.USD","LU1035775433.USD","LU1093756325.SGD","LU2089984988.USD","LLY","LU0354030511.USD","LU2360106947.USD","LU0256863811.USD","IE00B2B36J28.USD","LU0456855351.SGD","LU0094547139.USD","LU1023059063.AUD","LU1868836757.USD","LU2361044949.HKD","LU1366192091.USD","LU1868837300.USD","LU1720051108.HKD","SG9999018865.SGD","IE00BK4W5L77.USD","GPCR","BK4581","IE0004445239.USD","LU0238689110.USD","LU1712237335.SGD","SG9999017495.SGD","LU0114720955.EUR","LU1720051017.SGD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU2237443382.USD","LU1061106388.HKD","GLP","LU0417517546.SGD","LU0096364046.USD","VKTX","LU2237443465.HKD","BK4534","LU0471298777.SGD","LU2471134952.CNY","LU0943347566.SGD","LU1093756168.USD","LU2237443622.USD","NVO","LU2264538146.SGD","LU2106854487.HKD","LU2324357040.USD","LU1551013342.USD","III","LU1280957306.USD"],"gpt_icon":1},{"id":"2529809067","title":"Viking Therapeutics to Report Q1 Earnings: What's in the Cards?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809067","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529809067?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:36","pubTimestamp":1745235360,"startTime":"0","endTime":"0","summary":"We expect investors to focus on updates related to Viking Therapeutics’ VKTX pipeline when it reports first-quarter 2025 results on April 23, after market close. In the last reported quarter, the company’s earnings missed expectations by about 19%.Since the company lacks a marketed drug in its portfolio, we do not expect it to record revenues. The Zacks Consensus Estimate for earnings is pegged at a loss of 34 cents per share. . Our proven model does not predict an earnings beat for Viking this time around. The combination of a positive Earnings ESPand a Zacks Rank #1 , 2  or 3  increases the odds of an earnings beat. That is not thecase here, as you will see below. You can uncover the best stocks to buy or sell before they're reported with our Earnings ESP Filter.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-report-q1-earnings-113600173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VKTX"],"gpt_icon":0},{"id":"2528132340","title":"Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2528132340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528132340?lang=en_us&edition=fundamental","pubTime":"2025-04-19 03:20","pubTimestamp":1745004000,"startTime":"0","endTime":"0","summary":"Enthusiasm waned on Wall Street for weight-loss drug pioneer Novo Nordisk, after a pill tested by rival Eli Lilly produced as much weight loss as Novo's injectable Ozempic.Guggenheim's Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman at BMO Capital Markets.The Danish drug company's shares were down 13% on the week, to $58, after Lilly reported Thursday that its pill orforglipron had helped people lose up to 8% of their weight over 40 weeks. It also meaningfully reduced the A1C measure of diabetes in the ACHIEVE-1 Phase 3 trial. Side effects weren't troublesome.Pharmacies lose money on injectables like Ozempic and Mounjaro, says Fernandez, so they'll have incentive to push Lilly's pill.\"Novo's franchise is now also facing incremental price risk and in our view, will have to spend more aggressively on the [selling, general, and administrative expenses] line to promote a robust but increasingly challenged brand,\" says Fernande","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","AMGN","VKTX"],"gpt_icon":1},{"id":"2528937091","title":"H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data","url":"https://stock-news.laohu8.com/highlight/detail?id=2528937091","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528937091?lang=en_us&edition=fundamental","pubTime":"2025-04-18 23:55","pubTimestamp":1744991711,"startTime":"0","endTime":"0","summary":"H.C. Wainwright says the bar is set for oral GLP-1s following this morning’s type 2 diabetes data from Eli Lilly . The firm continues to expect Viking Therapeutics  to “differentiate” with its dual GLP-1/GIP asset VK2735. The data collected in the Phase 1 assessing oral VK2735 is at 28 days exhibited up to an 8.2% reduction in body weight was observed, and oral VK2735 maintained excellent tolerability profile through 100 mg dose level with 99% of adverse events being mild to moderate, the analyst tells investors in a research note. H.C. Wainwright believes Viking’s oral formulation of VK2735 “remains differentiated in the space” in terms of mechanism, efficacy, and safety. It keeps a Buy rating on Viking shares with a $102 price target. The stock in midday trading is down 2% to $23.22.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.JPMorgan says Lilly da","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/h-c-wainwright-still-expects-155511034.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/h-c-wainwright-still-expects-155511034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0354030511.USD","LU1804176565.USD","LU2552382132.HKD","LU2461242641.AUD","LU2265009873.SGD","LU2602419157.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1868837136.USD","VKTX","LU0198837287.USD","LU1868836591.USD","LU2237438978.USD","LU2237443549.SGD","IE00BJLML261.HKD","LU2324357040.USD","SG9999017495.SGD","LU1868836757.USD","SG9999015986.USD","IE00BK4W5M84.HKD","LU0882574055.USD","LU1917777945.USD","SG9999001176.USD","BK4007","IE0009355771.USD","SGXZ99366536.SGD","LU1057294990.SGD","LU2361045086.USD","LU2237443382.USD","LU1868836914.USD","LU1291159041.SGD","LU1548497426.USD","LU0417517546.SGD","LU0094547139.USD","LU1267930730.SGD","LLY","SG9999018857.SGD","LU2237443978.SGD","LU1093756168.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU0466842654.USD","BK4516","LU0006306889.USD","LU0203201768.USD","LU0097036916.USD","LU0471298777.SGD","LU2750360641.GBP","LU0106261372.USD","LU1064131342.USD"],"gpt_icon":1},{"id":"2528060378","title":"JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2528060378","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528060378?lang=en_us&edition=fundamental","pubTime":"2025-04-18 22:26","pubTimestamp":1744986368,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Hardik Parikh says Eli Lilly’s  Phase 3 data for orforglipron in type 2 diabetes suggest a “highly competitive profile” for the drug. The firm views the data as its base case scenario, whereby Structure Therapeutics  shares could be up double-digit percent in this scenario on a “highly favorable read-through” and Viking Therapeutics  could move mid-single-digit in either direction. JPMorgan’s focus was primarily on orfoglipron’s tolerability profile with the extended titration, and here the data is highlighted by an 8% discontinuation rate on the highest dose versus low-teens expectations, the analyst tells investors in a research note. The firm sees the data as “helping derisk the category,” giving more confidence that Structure can also bring tolerability of aleniglipron to reasonable levels. For Viking, the read-through is not as direct, and today’s data “clearly helps derisk a strong” first in class oral competitor from Lilly, which could limit the potential of lat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/jpmorgan-says-lilly-data-highly-142608655.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jpmorgan-says-lilly-data-highly-142608655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1883839398.USD","SG9999001176.USD","SG9999018865.SGD","IE0009355771.USD","BK4550","SG9999001176.SGD","LU2237443622.USD","SG9999014880.SGD","BK4585","LU0640476718.USD","LU1066051498.USD","IE00BJT1NW94.SGD","LU0238689110.USD","LU1267930730.SGD","LU0198837287.USD","LU2471134879.HKD","LU1291159041.SGD","LU2602419157.SGD","IE00B19Z3581.USD","LU2357305700.SGD","LU0256863902.USD","GPCR","LENZ","BK4516","LU2491050071.SGD","SG9999015945.SGD","SG9999018857.SGD","VKTX","LU1720051108.HKD","LU0689472784.USD","IE00BLSP4239.USD","LU2552382215.SGD","LU2237438978.USD","LU2237443895.HKD","LU0820561818.USD","LU1232071149.USD","LLY","LU0234572021.USD","LU0256863811.USD","LU2237443465.HKD","SG9999002224.SGD","SG9999015952.SGD","SGXZ51526630.SGD","LU1066053197.SGD","LU2023250504.SGD","LU0321505439.SGD","LU2324357040.USD","LU2360106947.USD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2528756777","title":"Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528756777","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528756777?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:50","pubTimestamp":1744926615,"startTime":"0","endTime":"0","summary":"Viking Therapeutics, Inc.  ended the recent trading session at $23.94, demonstrating a +1.44% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.13%. Meanwhile, the Dow lost 1.33%, and the Nasdaq, a tech-heavy index, lost 0.13%.The company's stock has dropped by 21.52% in the past month, falling short of the Medical sector's loss of 8.46% and the S&P 500's loss of 6.3%.Market participants will be closely following the financial results of Viking Therapeutics, Inc. in its upcoming release. The company plans to announce its earnings on April 23, 2025. The company's upcoming EPS is projected at -$0.34, signifying a 30.77% drop compared to the same quarter of the previous year.It is also important to note the recent changes to analyst estimates for Viking Therapeutics, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-beats-215015260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4599","ISBC","BK4585","BK4211","VKTX","BK4588","BK4139"],"gpt_icon":0},{"id":"2528726327","title":"Viking Therapeutics Price Target Maintained With a $102.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2528726327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528726327?lang=en_us&edition=fundamental","pubTime":"2025-04-18 00:57","pubTimestamp":1744909020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VKTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 17, 2025 12:57 ET (16:57 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VKTX"],"gpt_icon":0},{"id":"2528268817","title":"Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2528268817","media":"Motley Fool","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528268817?lang=en_us&edition=fundamental","pubTime":"2025-04-18 00:46","pubTimestamp":1744908360,"startTime":"0","endTime":"0","summary":"Eli Lilly has a plan to dominate the GLP-1 weight loss drug market -- and it's succeeding.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/04/17/eli-lilly-stock-soaring-novo-nordisk-viking-slide/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0689472784.USD","LU2361044865.SGD","LU0354030511.USD","LU1035775433.USD","LLY","LU1267930730.SGD","LU0097036916.USD","LU0058720904.USD","LU1974910355.USD","LU0823416689.USD","LU2211815571.USD","LU1093756325.SGD","LU1868837136.USD","SG9999015986.USD","VKTX","LU0417517546.SGD","LU2471134796.USD","LU0198837287.USD","LU1061106388.HKD","LU0289739699.SGD","LU1093756168.USD","LU2491050071.SGD","LU1623119135.USD","LU2461242641.AUD","BK4007","LU1868837300.USD","LU0882574055.USD","SG9999017495.SGD","LU2063271972.USD","LU1720051017.SGD","LU2471134523.USD","LU0354030438.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0006306889.USD","LU0061475181.USD","LU0456855351.SGD","SG9999001176.USD","LU2750360997.AUD","LU1548497426.USD","LU2471134879.HKD","BK4599","LU2112291526.USD","GB00BDT5M118.USD","SG9999014880.SGD","LU2468319806.SGD","IE00B2B36J28.USD","LU0385154629.USD","SGXZ81514606.USD"],"gpt_icon":1},{"id":"2528674819","title":"Shares of Some Obesity Drug Developers Fall After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2528674819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528674819?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:33","pubTimestamp":1744896814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1AE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2242652126.USD","BK4534","LU1057294990.SGD","BK4581","LU1023059063.AUD","BK4566","AMGN","LU1571399168.USD","BK4585","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0058720904.USD","LU2112291526.USD","BK4533","BK4599","LU2089984988.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","LU1061106388.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","IE00BJJMRZ35.SGD","VKTX","LU0122379950.USD","IE0002141913.USD","SG9999001440.SGD","LU0868494617.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2528174842","title":"U.S.-Listed Shares of Novo Nordisk Down 7.9%, Viking Therapeutics Down 3.9%, Amgen Down 3.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528174842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528174842?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:33","pubTimestamp":1744896814,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nFWN3QV1AE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","IE00BJJMRZ35.SGD","BK4599","BK4581","LU1023059063.AUD","IE0002141913.USD","LU2242652126.USD","LU2242646821.SGD","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","VKTX","IE00B2B36J28.USD","BK4585","LU0320765992.SGD","LU0868494617.USD","LU0122379950.USD","BK4588","IE00B4R5TH58.HKD","BK4566","IE0009355771.USD","LU1571399168.USD","LU2112291526.USD","BK4139","AMGN","LU2089984988.USD","BK4534","BK4533","IE00BJT1NW94.SGD","LU1061106388.HKD","LU0109394709.USD","SG9999001440.SGD","LU1057294990.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2528060710","title":"Lilly's Weight-Loss Pill Shocks Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2528060710","media":"GuruFocus.com","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528060710?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:05","pubTimestamp":1744895118,"startTime":"0","endTime":"0","summary":"Eli Lilly  may have just flipped the script on the obesity and diabetes drug market. The company's daily oral pill, orforglipron, delivered a nearly 8% average weight loss for Type 2 diabetes patients in a late-stage trialroughly 16 pounds over 40 weekswith no signs of plateauing. Blood sugar levels dropped by up to 1.6%, and the safety profile looked comparable to the weekly injections currently dominating the market. While the A1c reductions came in slightly below some bullish analyst expectations, the overall data reinforced Lilly's confidence in orforglipron as a next-gen contender.Analysts have been watching this study like hawks, and for good reason: this is the first real shot at a needle-free GLP-1 drug that could scale globally. Side effects like nausea and vomiting were within expectations, with only 8% of patients discontinuing at the highest dose. That's actually better than the 9% discontinuation rate some analysts penciled in. More importantly, orforglipron's convenience ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lillys-weight-loss-pill-shocks-130518909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","SG9999014906.USD","LU1917777945.USD","LU1023059063.AUD","LU1712237335.SGD","LU1989771016.USD","LU1093756168.USD","LU1720051108.HKD","LU2023250504.SGD","LU2461242641.AUD","SG9999015952.SGD","LU0097036916.USD","LU1623119135.USD","LU2456880835.USD","SG9999018857.SGD","SG9999001176.SGD","LU1868837300.USD","LU2471134523.USD","SGXZ81514606.USD","LLY","LU2491049909.HKD","LU2361045086.USD","LU2491050154.USD","LU1551013342.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","LU0094547139.USD","GB00BDT5M118.USD","IE0009355771.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","VKTX","LU0943347566.SGD","LU0672654240.SGD","SG9999014880.SGD","LU0114720955.EUR","SG9999013999.USD","LU0203202063.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU2324357040.USD","LU0820561818.USD","LU2237443549.SGD","LU2063271972.USD","AZN","SG9999014898.SGD","LU2471134879.HKD","LU2236285917.USD"],"gpt_icon":1},{"id":"2528671237","title":"BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2528671237","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528671237?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:53","pubTimestamp":1744894413,"startTime":"0","endTime":"0","summary":"BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trialUpdates** Shares of drugmaker Eli Lilly LLY.N rise 12.7% to $828.67 premarket** Company says its small molecule oral drug orforglipron led to an average weight loss of 7.9% and lowered blood sugar for overweight patients with type 2 diabetes in a late-stage trial** Shares of Structure Therapeutics GPCR.O, which is also developing a small molecule oral weight loss drug, gain 17.7% before the bell** U.S.-listed shares of Lilly's obesity drug rival Novo Nordisk NOVOb.CO down 6%** Other weight-loss drug developers such as Viking Therapeutics VKTX.O down 5.1% and Amgen AMGN.O down 2.8%** Up to last close, LLY shares down 4.8%, VKTX down 41.2% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV176:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","LU0882574139.USD","LU0820561818.USD","LU1868836914.USD","IE0009355771.USD","LU2491050154.USD","GPCR","LU2237443978.SGD","BK4599","LU2237438978.USD","SG9999014906.USD","LU1548497426.USD","LU2750360997.AUD","SGXZ31699556.SGD","LU2357305700.SGD","LU1093756325.SGD","AMGN","SG9999001440.SGD","LU1720051108.HKD","LU0889565916.HKD","LU0943347566.SGD","LU1093756168.USD","LU0203202063.USD","BK4533","SGXZ51526630.SGD","LU2360106947.USD","LU2237443622.USD","LU1551013425.SGD","LU2468319806.SGD","VKTX","LU0122379950.USD","LU0417517546.SGD","LU0058720904.USD","LU0106261372.USD","LU0256863811.USD","SGXZ99366536.SGD","LU1366192091.USD","LU1057294990.SGD","LLY","LU0289739699.SGD","LU2242646821.SGD","LU0096364046.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1988902786.USD","LU0820561909.HKD","LU2361044865.SGD","SG9999014898.SGD","LU0109391861.USD"],"gpt_icon":1},{"id":"2528715206","title":"Eli Lilly's stock soars as successful trial of weight-loss pill is a game changer","url":"https://stock-news.laohu8.com/highlight/detail?id=2528715206","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528715206?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:48","pubTimestamp":1744890480,"startTime":"0","endTime":"0","summary":"If approved, the pill is expected to be far easier to administer than current injectables-and far easier to manufacture. Eli Lilly & Co.'s Inc.'s stock soared 11% early Thursday, after the drug maker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form.The company  said the drug called orforglipron showed statistically significant results in the Phase 3 trial and a safety profile that was consistent with injectable GLP-1 medicines. The once-daily treatment lowered A1C by an average of 1.3% to 1.6% across doses at 40 weeks, and reduced weight by an average of 16 lbs. at the highest dose. A1C is a test used to measure blood sugar.The drug is the first oral small-molecule GLP-receptor agonist to successfully complete a Phase 3 trial, said Lilly in a statement. For now, the popular new class of drugs only exists in injectable form and a pill version is expected to be a game-changer given the greater ease with which it can be ad","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0154236417.USD","LU2552382058.USD","LU2112291526.USD","LU2211815571.USD","LU2237443465.HKD","SG9999014880.SGD","BK4581","LU0820561818.USD","LU1057294990.SGD","LU0354030511.USD","VKTX","LU0256863902.USD","LU2237443895.HKD","LU2491050154.USD","SG9999013999.USD","LU2471134952.CNY","BK4534","LLY","IE00B1BXHZ80.USD","LU1720051017.SGD","SG9999018865.SGD","LU0385154629.USD","BK4516","LU2089984988.USD","LU1069344957.HKD","TERN","LU1291159041.SGD","LU2106854487.HKD","LU0708995401.HKD","LU2237438978.USD","LU2265009873.SGD","SG9999015986.USD","LU0109391861.USD","LU0289739699.SGD","LU0114720955.EUR","LU2324357040.USD","SGXZ57979304.SGD","LU1868837136.USD","LU0882574055.USD","LU0471298694.HKD","LU1061106388.HKD","LU2237443622.USD","LU0203202063.USD","LU2491050071.SGD","LU2552382132.HKD","LU1366192091.USD","LU0640476718.USD","LU0466842654.USD"],"gpt_icon":1},{"id":"2528790323","title":"Shares of Obesity Drug Developer Viking Therapeutics Falls 5.3% Premarket After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2528790323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528790323?lang=en_us&edition=fundamental","pubTime":"2025-04-17 19:02","pubTimestamp":1744887756,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV10E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0203201768.USD","LU0943347566.SGD","LU1061106388.HKD","SG9999015986.USD","IE00BFTCPJ56.SGD","LU1127390331.HKD","BK4139","LU1868837136.USD","LU1917777945.USD","LU0106261372.USD","LU1093756168.USD","LU1548497426.USD","LU1291159041.SGD","LU2089984988.USD","LU0122379950.USD","LU2471134952.CNY","BK4585","SG9999014898.SGD","SG9999017495.SGD","IE00B2B36J28.USD","LU0354030438.USD","VKTX","LU1064131342.USD","IE0009355771.USD","LU0238689110.USD","SGXZ99366536.SGD","LU1814569148.SGD","LLY","SG9999015978.USD","BK4516","LU2237443465.HKD","LU2602419157.SGD","SG9999015952.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","SG9999001176.SGD","SG9999018865.SGD","LU2361044865.SGD","SG9999014906.USD","LU1868836757.USD","LU2237443382.USD","IE00BJLML261.HKD","LU0079474960.USD","LU1035775433.USD","SGXZ81514606.USD","SGXZ57979304.SGD","LU0097036916.USD","LU1280957306.USD","LU1023059063.AUD","LU2552382058.USD"],"gpt_icon":0},{"id":"2528708072","title":"Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528708072","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528708072?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:05","pubTimestamp":1744833900,"startTime":"0","endTime":"0","summary":"Conference Call Scheduled for Wednesday, April 23 at 4:30 p.m. Eastern Time. SAN DIEGO, April 16, 2025 /PRNewswire/ --Viking Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will release financial results for the first quarter 2025 after the market close on Wednesday, April 23, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/viking-therapeutics-report-financial-results-200500522.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-report-financial-results-200500522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","VKTX","BK4139","BK4599","AMN","BK4196","BK4588"],"gpt_icon":0},{"id":"2527243766","title":"Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527243766","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527243766?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:05","pubTimestamp":1744801500,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company’s LLY shares have lost 8.2% in the past month. A lot of this price decline is due to the global uncertainty caused by the tariff war. With the Trump administration imposing sweeping tariffs, fears of a global recession resulted in a stock market rout worldwide. Though pharmaceuticals have been exempted from tariffs in the first round of reciprocal tariffs, they could well be Trump’s target in the next round, considering the President’s goal to shift pharmaceutical productionback to the United States, mostly from European and Asian countries.Stocks of both Lilly and rival Novo Nordisk NVO declined recently as Medicare excluded their expensive weight-loss medicines from its Part D prescription drug coverage.Let’s understand the company’s strengths and weaknesses to better analyze how to play the stock amid the broader market uncertainty.Despite being on the market for less than three years, Mounjaro and Zepbound became key top-line drivers for Lilly in 2024, with de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-stock-down-8-110500046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1720051017.SGD","BK4532","LU1989771016.USD","LU2237443895.HKD","SG9999018865.SGD","LU1814569148.SGD","LU1917777945.USD","IE00BKVL7J92.USD","IE00B1BXHZ80.USD","LU1057294990.SGD","NVO","SGXZ57979304.SGD","LU0943347566.SGD","LU0109394709.USD","LU0203202063.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","SG9999015945.SGD","LU1868836757.USD","LU1868837136.USD","LU2112291526.USD","SGXZ51526630.SGD","LU1291159041.SGD","SGXZ99366536.SGD","LU0154236417.USD","LU0198837287.USD","LU1804176565.USD","LU2471134796.USD","LU2237443382.USD","BK4566","LU1571399168.USD","LU0385154629.USD","LU1988902786.USD","LU2461242641.AUD","GB00BDT5M118.USD","LU0823416689.USD","LU0289739699.SGD","VKTX","LU0106261372.USD","LU2552382215.SGD","LU1623119135.USD","LU0096364046.USD","LU2471134879.HKD","LU1551013425.SGD","LU1267930730.SGD","LU0882574139.USD","LU2491050154.USD","LLY","AMGN","IE00BJJMRZ35.SGD"],"gpt_icon":1},{"id":"2527251342","title":"Viking Therapeutics’ VK2735: A Promising Contender Amidst Pfizer’s Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2527251342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527251342?lang=en_us&edition=fundamental","pubTime":"2025-04-16 15:35","pubTimestamp":1744788926,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Thomas Smith has maintained their bullish stance on VKTX stock, giving a Buy rating on April 14. Thomas Smith’s rating is ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/viking-therapeutics-vk2735-a-promising-contender-amidst-pfizers-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/viking-therapeutics-vk2735-a-promising-contender-amidst-pfizers-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0306807586.USD","BK4592","LU0058720904.USD","LU1894683348.USD","LU0122379950.USD","LU0234572021.USD","LU1066053197.SGD","LU1023059063.AUD","SG9999001176.SGD","SGXZ57979304.SGD","LU1066051498.USD","SG9999002224.SGD","SG9999002232.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU0985481810.HKD","BK4139","LU0225771236.USD","BK4568","VKTX","BK4581","LU1057294990.SGD","IE0002270589.USD","SG9999001176.USD","BK4585","LU0170899867.USD","IE00BBT3K403.USD","LU1883839398.USD","IE00B19Z3581.USD","BK4007","LU0225284248.USD","LU0289739699.SGD","BK4588","LU0456855351.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","IE00BLSP4239.USD","LU0321505868.SGD","SG9999003800.SGD","LU0321505439.SGD","LU0306806265.USD","SG9999011175.SGD","BK4550","BK4533","LU1894683264.USD","IE000M9KFDE8.USD","BK4534","BK4599"],"gpt_icon":0},{"id":"2527425964","title":"Promising Pipeline and Strategic Developments Drive Buy Rating for Viking Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2527425964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527425964?lang=en_us&edition=fundamental","pubTime":"2025-04-16 01:25","pubTimestamp":1744737931,"startTime":"0","endTime":"0","summary":"BTIG analyst Jeet Mukherjee has reiterated their bullish stance on VKTX stock, giving a Buy rating yesterday. Jeet Mukherjee’s rating is based on s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-developments-drive-buy-rating-for-viking-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-developments-drive-buy-rating-for-viking-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VKTX"],"gpt_icon":0},{"id":"2527092429","title":"Pfizer Halts Obesity Pill Development Amid Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2527092429","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527092429?lang=en_us&edition=fundamental","pubTime":"2025-04-16 00:57","pubTimestamp":1744736220,"startTime":"0","endTime":"0","summary":"Pfizer PFE announced that it is discontinuing the development of danuglipron, its investigational oral GLP-1 receptor agonist , which is being developed to treat obesity.The decision follows a safety signal observed during two dose-optimization studies, in which one study participant experienced a case of potential drug-induced liver injury. Although the individual was asymptomatic and fully recovered after stopping the treatment, Pfizer stated that its decision was based on a comprehensive review of all clinical data generated to date, along with recent regulatory feedback.While the two dose-optimization studies had met key pharmacokinetic goals and identified a dose with the potential for competitive efficacy and tolerability, the safety concerns ultimately led Pfizer to stop further development of danuglipron.The obesity market has garnered much interest lately. Per a research conducted by Goldman Sachs, the obesity market in the United States is expected to reach $100 billion by 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-halts-obesity-pill-development-165700605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1712237335.SGD","IE0002270589.USD","LU0943347566.SGD","LU1623119135.USD","IE00BZ1G4Q59.USD","LU0823416689.USD","IE0004445239.USD","LU0471298777.SGD","LU2112291526.USD","LU2357305700.SGD","SG9999014880.SGD","LU0354030438.USD","LU1066051498.USD","LU0820561818.USD","LU0094547139.USD","LU2471134796.USD","LU1280957306.USD","VKTX","NVO","IE00B19Z3B42.SGD","SG9999018857.SGD","LU0225771236.USD","IE00B4R5TH58.HKD","LU1894683264.USD","PFE","SG9999002224.SGD","SG9999014906.USD","IE00BKVL7J92.USD","LU1988902786.USD","LLY","IE00BLSP4239.USD","LU1868836591.USD","LU2063271972.USD","SG9999017495.SGD","BK4516","LU1883839398.USD","LU2361044949.HKD","LU2106854487.HKD","LU0417517546.SGD","LU1551013425.SGD","LU2237438978.USD","BK4592","LU2237443622.USD","LU1989771016.USD","LU2361044865.SGD","SG9999002232.USD","LU0203202063.USD","LU1366192091.USD","LU1868836914.USD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2527444107","title":"NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2527444107","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527444107?lang=en_us&edition=fundamental","pubTime":"2025-04-15 22:00","pubTimestamp":1744725600,"startTime":"0","endTime":"0","summary":"Obesity stocks like Novo Nordisk NVO, Eli Lilly LLY, Structure Therapeutics GPCR and Viking Therapeutics VKTX gained 2.1%, 3%, 10.6% and 19.2%, respectively, on Monday after pharma bigwig Pfizer PFE announced that it is discontinuing the development of its GLP-1R weight loss pill, danuglipron.After reviewing all clinical data and considering regulatory feedback, Pfizer concluded that halting the program was the best course of action. This decision reverted Pfizer’s developmental program for an obesity candidate back to the early clinical stages and has significantly delayed its hopes for marketing an obesity drug that would compete with Lilly’s Zepbound and Novo Nordisk’s Wegovy for market share.How PFE’s Obesity Study Setback Benefits VKTX, GPCR, LLY & NVO. Shares of Lilly, Novo Nordisk, Viking Therapeutics and Structure Therapeutics rose as Pfizer's decision to discontinue its obesity pill program removes a ke","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-lly-gpcr-vktx-stocks-140000975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1868836757.USD","LU0882574055.USD","LU0456855351.SGD","LU0985481810.HKD","LU2361044865.SGD","SG9999013999.USD","LU1127390331.HKD","LU0096364046.USD","BK4581","LU1894683348.USD","SG9999014914.USD","LU0203202063.USD","SG9999011175.SGD","LU1983299246.USD","LU1712237335.SGD","GPCR","SGXZ99366536.SGD","LU1551013425.SGD","IE0002141913.USD","LU0820561909.HKD","LU1291159041.SGD","VKTX","LLY","LU2360106947.USD","LU1868837300.USD","LU0289739699.SGD","LU0672654240.SGD","LU1917777945.USD","LU0868494617.USD","LU1232071149.USD","LU0058720904.USD","PFE","NVO","BK4588","LU2471134952.CNY","LU2237443465.HKD","BK4568","IE000M9KFDE8.USD","IE00BZ1G4Q59.USD","LU1069344957.HKD","BK4599","LU1093756325.SGD","LU0354030438.USD","LU2552382058.USD","BK4532","IE00BJT1NW94.SGD","LU1883839398.USD","LU0106261372.USD","IE00BLSP4452.SGD","SGXZ81514606.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VKTX\",params:#limit:5,,,undefined,":[{"date":"2025-04-23","symbol":"VKTX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"defaultRemindTime":1745438400000,"name":null,"time":"Post Market","dateTimestamp":1745380800000,"actualEps":null},{"market":"US","date":"2025-02-05","symbol":"VKTX","fiscalQuarterEnding":"2024/12","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738731600000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-10-23","symbol":"VKTX","fiscalQuarterEnding":"2024/09","expectedEps":-0.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1729656000000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2024-07-24","symbol":"VKTX","fiscalQuarterEnding":"2024/06","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1721793600000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2024-04-24","symbol":"VKTX","fiscalQuarterEnding":"2024/03","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"post","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VKTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VKTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.5,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":18,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VKTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VKTX","date":"2025-04-17","current":-24.09036,"percent":0.285483,"low":-119.243765,"twenty":-31.7768,"median":-13.537772,"eighty":-6.999702,"high":-2.86002,"avg":-23.737952,"sd":24.080295,"marketCap":2649048292},"quantilePoints":[{"date":"2020-04-24","current":-16.916979,"twenty":-28.408951,"median":-10.19753,"eighty":-1.409397,"marketCap":436102806},{"date":"2020-05-01","current":-12.954313,"twenty":-28.217552,"median":-10.222281,"eighty":-1.409943,"marketCap":395650641},{"date":"2020-05-08","current":-15.497637,"twenty":-28.073994,"median":-10.222281,"eighty":-1.409943,"marketCap":473328840},{"date":"2020-05-15","current":-16.876262,"twenty":-27.752939,"median":-10.222281,"eighty":-1.409943,"marketCap":515434780},{"date":"2020-05-22","current":-18.896659,"twenty":-27.520316,"median":-10.222281,"eighty":-1.409943,"marketCap":577141761},{"date":"2020-05-29","current":-16.995108,"twenty":-27.38396,"median":-10.222281,"eighty":-1.409943,"marketCap":519064603},{"date":"2020-06-05","current":-17.541804,"twenty":-27.29474,"median":-10.222281,"eighty":-1.409943,"marketCap":535761786},{"date":"2020-06-12","current":-17.232802,"twenty":-27.041821,"median":-10.222281,"eighty":-1.409943,"marketCap":526324248},{"date":"2020-06-19","current":-18.005307,"twenty":-26.888087,"median":-10.222281,"eighty":-1.409943,"marketCap":549918093},{"date":"2020-06-26","current":-17.969653,"twenty":-26.598239,"median":-10.222281,"eighty":-1.409943,"marketCap":548829146},{"date":"2020-07-02","current":-15.877947,"twenty":-26.369161,"median":-10.222281,"eighty":-1.409943,"marketCap":484944272},{"date":"2020-07-10","current":-16.186949,"twenty":-26.115599,"median":-10.222281,"eighty":-1.409943,"marketCap":494381810},{"date":"2020-07-17","current":-16.876262,"twenty":-25.931073,"median":-10.222281,"eighty":-1.409943,"marketCap":515434780},{"date":"2020-07-24","current":-16.044333,"twenty":-25.759126,"median":-10.222281,"eighty":-1.409943,"marketCap":490026024},{"date":"2020-07-31","current":-15.744869,"twenty":-25.659974,"median":-10.222281,"eighty":-1.409943,"marketCap":510763560},{"date":"2020-08-07","current":-16.888727,"twenty":-25.571396,"median":-10.222281,"eighty":-1.409943,"marketCap":547870315},{"date":"2020-08-14","current":-16.507441,"twenty":-25.399289,"median":-10.222281,"eighty":-1.409943,"marketCap":535501397},{"date":"2020-08-21","current":-17.785871,"twenty":-25.399289,"median":-10.482169,"eighty":-1.409943,"marketCap":576973652},{"date":"2020-08-28","current":-15.318726,"twenty":-25.399289,"median":-10.862146,"eighty":-1.409943,"marketCap":496939475},{"date":"2020-09-04","current":-13.726296,"twenty":-25.399289,"median":-11.2704,"eighty":-1.409943,"marketCap":445281053},{"date":"2020-09-11","current":-12.851581,"twenty":-25.399289,"median":-11.467303,"eighty":-1.409943,"marketCap":416905299},{"date":"2020-09-18","current":-15.341155,"twenty":-25.399289,"median":-11.849701,"eighty":-1.409943,"marketCap":497667059},{"date":"2020-09-25","current":-13.524439,"twenty":-25.399289,"median":-12.144044,"eighty":-1.409943,"marketCap":438732802},{"date":"2020-10-02","current":-12.447867,"twenty":-25.399289,"median":-12.388496,"eighty":-1.409943,"marketCap":403808798},{"date":"2020-10-09","current":-13.726296,"twenty":-25.399289,"median":-12.482803,"eighty":-1.409943,"marketCap":445281053},{"date":"2020-10-16","current":-13.232867,"twenty":-25.399289,"median":-12.79011,"eighty":-1.409943,"marketCap":429274217},{"date":"2020-10-23","current":-12.829153,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":416177716},{"date":"2020-10-30","current":-11.409829,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":410719602},{"date":"2020-11-06","current":-12.261006,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":441359430},{"date":"2020-11-13","current":-12.34207,"twenty":-25.399289,"median":-12.840367,"eighty":-1.409943,"marketCap":444277509},{"date":"2020-11-20","current":-12.787925,"twenty":-25.399289,"median":-12.851581,"eighty":-1.409943,"marketCap":460326943},{"date":"2020-11-27","current":-13.537772,"twenty":-25.399289,"median":-12.879123,"eighty":-1.410746,"marketCap":487319172},{"date":"2020-12-04","current":-12.828457,"twenty":-25.399289,"median":-12.921785,"eighty":-1.415684,"marketCap":461785982},{"date":"2020-12-11","current":-12.747393,"twenty":-25.399289,"median":-12.921785,"eighty":-1.417603,"marketCap":458867903},{"date":"2020-12-18","current":-13.010853,"twenty":-25.399289,"median":-13.042279,"eighty":-1.417603,"marketCap":468351660},{"date":"2020-12-24","current":-12.564998,"twenty":-25.399289,"median":-13.042279,"eighty":-1.42011,"marketCap":452302226},{"date":"2020-12-31","current":-11.409829,"twenty":-25.399289,"median":-13.042279,"eighty":-1.420969,"marketCap":410719602},{"date":"2021-01-08","current":-13.456707,"twenty":-25.399289,"median":-13.071141,"eighty":-1.430842,"marketCap":484401094},{"date":"2021-01-15","current":-13.132449,"twenty":-25.399289,"median":-13.137801,"eighty":-1.432871,"marketCap":472728778},{"date":"2021-01-22","current":-13.821498,"twenty":-25.399289,"median":-13.178407,"eighty":-1.441415,"marketCap":497532449},{"date":"2021-01-29","current":-14.814538,"twenty":-25.399289,"median":-13.255296,"eighty":-1.443614,"marketCap":533278915},{"date":"2021-02-05","current":-19.597343,"twenty":-25.399289,"median":-13.349423,"eighty":-1.450892,"marketCap":705445569},{"date":"2021-02-12","current":-17.003279,"twenty":-25.399289,"median":-13.476973,"eighty":-1.4635,"marketCap":612067045},{"date":"2021-02-19","current":-14.396785,"twenty":-25.399289,"median":-13.536713,"eighty":-1.490029,"marketCap":568601038},{"date":"2021-02-26","current":-12.651152,"twenty":-25.399289,"median":-13.536713,"eighty":-1.520167,"marketCap":499657235},{"date":"2021-03-05","current":-12.482219,"twenty":-25.411586,"median":-13.537772,"eighty":-1.598396,"marketCap":492985254},{"date":"2021-03-12","current":-12.669922,"twenty":-25.411586,"median":-13.537772,"eighty":-1.619034,"marketCap":500398566},{"date":"2021-03-19","current":-11.80649,"twenty":-25.411586,"median":-13.537772,"eighty":-1.632817,"marketCap":466297331},{"date":"2021-03-26","current":-11.637558,"twenty":-25.399289,"median":-13.536713,"eighty":-1.647407,"marketCap":459625350},{"date":"2021-04-01","current":-11.78772,"twenty":-25.399289,"median":-13.536713,"eighty":-1.667605,"marketCap":465555999},{"date":"2021-04-09","current":-11.568407,"twenty":-25.411586,"median":-13.537772,"eighty":-1.683821,"marketCap":456894239},{"date":"2021-04-16","current":-11.470701,"twenty":-25.411586,"median":-13.537772,"eighty":-1.69996,"marketCap":453035335},{"date":"2021-04-23","current":-11.763819,"twenty":-25.411586,"median":-13.537772,"eighty":-1.716245,"marketCap":464612047},{"date":"2021-04-30","current":-11.389385,"twenty":-25.399289,"median":-13.536713,"eighty":-1.728163,"marketCap":499060073},{"date":"2021-05-07","current":-10.516021,"twenty":-25.399289,"median":-13.536713,"eighty":-1.748072,"marketCap":460790991},{"date":"2021-05-14","current":-10.997262,"twenty":-25.399289,"median":-13.536713,"eighty":-1.764364,"marketCap":481878036},{"date":"2021-05-21","current":-10.676434,"twenty":-25.399289,"median":-13.536713,"eighty":-1.780463,"marketCap":467820006},{"date":"2021-05-28","current":-9.339652,"twenty":-25.399289,"median":-13.536713,"eighty":-1.785641,"marketCap":409244880},{"date":"2021-06-04","current":-9.3753,"twenty":-25.399289,"median":-13.536713,"eighty":-1.828278,"marketCap":410806883},{"date":"2021-06-11","current":-10.836848,"twenty":-25.399289,"median":-13.536713,"eighty":-1.8479,"marketCap":474849021},{"date":"2021-06-18","current":-10.943791,"twenty":-25.399289,"median":-13.536713,"eighty":-1.882568,"marketCap":479535031},{"date":"2021-06-25","current":-11.995393,"twenty":-25.399289,"median":-13.536713,"eighty":-1.943791,"marketCap":525614130},{"date":"2021-07-02","current":-11.03291,"twenty":-25.399289,"median":-13.536713,"eighty":-1.966643,"marketCap":483440039},{"date":"2021-07-09","current":-10.997262,"twenty":-25.399289,"median":-13.536713,"eighty":-1.977985,"marketCap":481878036},{"date":"2021-07-16","current":-10.409078,"twenty":-25.399289,"median":-13.536713,"eighty":-2.013559,"marketCap":456104981},{"date":"2021-07-23","current":-10.284312,"twenty":-25.399289,"median":-13.536713,"eighty":-2.028597,"marketCap":450637969},{"date":"2021-07-30","current":-9.689632,"twenty":-25.399289,"median":-13.536713,"eighty":-2.052782,"marketCap":480867356},{"date":"2021-08-06","current":-9.642365,"twenty":-25.399289,"median":-13.536713,"eighty":-2.068819,"marketCap":478521661},{"date":"2021-08-13","current":-9.3115,"twenty":-25.399289,"median":-13.536713,"eighty":-2.079369,"marketCap":462101800},{"date":"2021-08-20","current":-9.138189,"twenty":-25.399289,"median":-13.536713,"eighty":-2.084856,"marketCap":453500921},{"date":"2021-08-27","current":-9.815676,"twenty":-25.399289,"median":-13.536713,"eighty":-2.100894,"marketCap":487122541},{"date":"2021-09-03","current":-10.713739,"twenty":-25.399289,"median":-13.536713,"eighty":-2.116931,"marketCap":531690735},{"date":"2021-09-10","current":-10.398629,"twenty":-25.399289,"median":-13.536713,"eighty":-2.137786,"marketCap":516052772},{"date":"2021-09-17","current":-10.540429,"twenty":-25.399289,"median":-13.536713,"eighty":-2.248379,"marketCap":523089855},{"date":"2021-09-24","current":-10.209563,"twenty":-25.399289,"median":-13.536713,"eighty":-2.477122,"marketCap":506669994},{"date":"2021-10-01","current":-9.673876,"twenty":-25.399289,"median":-13.536713,"eighty":-3.066451,"marketCap":480085457},{"date":"2021-10-08","current":-9.48481,"twenty":-25.386992,"median":-13.535653,"eighty":-3.422547,"marketCap":470702680},{"date":"2021-10-15","current":-9.469055,"twenty":-25.386992,"median":-13.535653,"eighty":-3.746445,"marketCap":469920782},{"date":"2021-10-22","current":-9.075167,"twenty":-25.386992,"median":-13.535653,"eighty":-3.931498,"marketCap":450373328},{"date":"2021-10-29","current":-9.1697,"twenty":-25.386992,"median":-13.535653,"eighty":-4.134737,"marketCap":455064717},{"date":"2021-11-05","current":-9.53443,"twenty":-25.386992,"median":-13.535653,"eighty":-4.513878,"marketCap":510873825},{"date":"2021-11-12","current":-8.979593,"twenty":-25.386992,"median":-13.535653,"eighty":-4.798493,"marketCap":481144567},{"date":"2021-11-19","current":-8.234944,"twenty":-25.386992,"median":-13.535653,"eighty":-4.900663,"marketCap":441244773},{"date":"2021-11-26","current":-7.855319,"twenty":-25.386992,"median":-13.535653,"eighty":-5.011337,"marketCap":420903702},{"date":"2021-12-03","current":-7.169074,"twenty":-25.386992,"median":-13.535653,"eighty":-5.341054,"marketCap":384133304},{"date":"2021-12-10","current":-7.081468,"twenty":-25.386992,"median":-13.535653,"eighty":-7.300482,"marketCap":379439211},{"date":"2021-12-17","current":-7.169074,"twenty":-25.386992,"median":-13.535653,"eighty":-7.300482,"marketCap":384133304},{"date":"2021-12-23","current":-7.5633,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":405256725},{"date":"2021-12-31","current":-6.716444,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":359880489},{"date":"2022-01-07","current":-6.132405,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":328586533},{"date":"2022-01-14","current":-6.190809,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":331715929},{"date":"2022-01-21","current":-5.562968,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":298074927},{"date":"2022-01-28","current":-5.227145,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":280080902},{"date":"2022-02-04","current":-5.183342,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":277733855},{"date":"2022-02-11","current":-5.529152,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":304048067},{"date":"2022-02-18","current":-4.845133,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":266433873},{"date":"2022-02-25","current":-4.887884,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":268784760},{"date":"2022-03-04","current":-4.531625,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":249194034},{"date":"2022-03-11","current":-4.531625,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":249194034},{"date":"2022-03-18","current":-4.802382,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":264082986},{"date":"2022-03-25","current":-4.474623,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":246059518},{"date":"2022-04-01","current":-4.460373,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":245275889},{"date":"2022-04-08","current":-4.132614,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":227252421},{"date":"2022-04-14","current":-3.933108,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":216281615},{"date":"2022-04-22","current":-3.420094,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":188070969},{"date":"2022-04-29","current":-3.225994,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":184149434},{"date":"2022-05-06","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-05-13","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-05-20","current":-3.090448,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":176412063},{"date":"2022-05-27","current":-3.158221,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":180280748},{"date":"2022-06-03","current":-3.171776,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":181054486},{"date":"2022-06-10","current":-3.022675,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":172543377},{"date":"2022-06-17","current":-3.049785,"twenty":-25.374695,"median":-13.530046,"eighty":-7.315083,"marketCap":174090852},{"date":"2022-06-24","current":-3.903724,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":222836290},{"date":"2022-07-01","current":-3.822397,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":218193867},{"date":"2022-07-08","current":-4.622118,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":263844357},{"date":"2022-07-15","current":-5.015201,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":286282734},{"date":"2022-07-22","current":-4.581454,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":261523146},{"date":"2022-07-29","current":-3.903546,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":230832318},{"date":"2022-08-05","current":-4.448227,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":263041479},{"date":"2022-08-12","current":-4.876191,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":288348677},{"date":"2022-08-19","current":-4.616819,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":273010981},{"date":"2022-08-26","current":-4.318541,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":255372631},{"date":"2022-09-02","current":-4.111044,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":243102475},{"date":"2022-09-09","current":-4.085107,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":241568705},{"date":"2022-09-16","current":-4.188856,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":247703783},{"date":"2022-09-23","current":-3.449646,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":203991351},{"date":"2022-09-30","current":-3.527457,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":208592660},{"date":"2022-10-07","current":-3.721986,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":220095931},{"date":"2022-10-14","current":-4.24073,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":250771323},{"date":"2022-10-21","current":-5.317123,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":314422759},{"date":"2022-10-28","current":-5.173587,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":319024068},{"date":"2022-11-04","current":-5.273079,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":325159146},{"date":"2022-11-11","current":-5.19846,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":320557838},{"date":"2022-11-18","current":-4.974603,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":306753912},{"date":"2022-11-25","current":-4.987039,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":307520796},{"date":"2022-12-02","current":-5.297952,"twenty":-25.386992,"median":-13.535653,"eighty":-7.469854,"marketCap":326692916},{"date":"2022-12-09","current":-4.576635,"twenty":-25.386992,"median":-13.535653,"eighty":-7.244999,"marketCap":282213599},{"date":"2022-12-16","current":-4.999476,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":308287681},{"date":"2022-12-23","current":-10.508849,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":648017639},{"date":"2022-12-30","current":-11.690317,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":720871693},{"date":"2023-01-06","current":-10.496412,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":647250754},{"date":"2023-01-13","current":-11.130674,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":686361878},{"date":"2023-01-20","current":-10.794888,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":665655989},{"date":"2023-01-27","current":-10.658087,"twenty":-25.386992,"median":-13.535653,"eighty":-7.119431,"marketCap":657220256},{"date":"2023-02-03","current":-11.317222,"twenty":-25.386992,"median":-13.524439,"eighty":-7.119431,"marketCap":697865149},{"date":"2023-02-10","current":-12.149879,"twenty":-25.386992,"median":-13.434725,"eighty":-7.119431,"marketCap":836725704},{"date":"2023-02-17","current":-12.85587,"twenty":-25.386992,"median":-13.334708,"eighty":-7.119431,"marketCap":885345192},{"date":"2023-02-24","current":-12.525648,"twenty":-25.386992,"median":-13.255296,"eighty":-7.119431,"marketCap":862603819},{"date":"2023-03-03","current":-13.470765,"twenty":-25.386992,"median":-13.213514,"eighty":-7.119431,"marketCap":927691198},{"date":"2023-03-10","current":-11.785496,"twenty":-25.386992,"median":-13.158792,"eighty":-7.119431,"marketCap":811631775},{"date":"2023-03-17","current":-13.470765,"twenty":-25.386992,"median":-13.120724,"eighty":-7.119431,"marketCap":927691198},{"date":"2023-03-24","current":-10.077453,"twenty":-25.386992,"median":-13.112183,"eighty":-7.119431,"marketCap":694003981},{"date":"2023-03-31","current":-23.127881,"twenty":-25.374695,"median":-13.132194,"eighty":-7.122351,"marketCap":1592747807},{"date":"2023-04-06","current":-27.368372,"twenty":-25.498525,"median":-13.200762,"eighty":-7.122351,"marketCap":1884777689},{"date":"2023-04-14","current":-31.225434,"twenty":-25.600181,"median":-13.255296,"eighty":-7.119431,"marketCap":2150401995},{"date":"2023-04-21","current":-29.188583,"twenty":-25.700564,"median":-13.388585,"eighty":-7.119431,"marketCap":2010130121},{"date":"2023-04-28","current":-26.649427,"twenty":-25.824845,"median":-13.470765,"eighty":-7.119431,"marketCap":1926620316},{"date":"2023-05-05","current":-29.92626,"twenty":-25.971096,"median":-13.535653,"eighty":-7.119431,"marketCap":2163518996},{"date":"2023-05-12","current":-31.6387,"twenty":-26.182902,"median":-13.578304,"eighty":-7.119431,"marketCap":2287319806},{"date":"2023-05-19","current":-32.01157,"twenty":-26.537926,"median":-13.59857,"eighty":-7.119431,"marketCap":2314276434},{"date":"2023-05-26","current":-28.862891,"twenty":-26.646108,"median":-13.636582,"eighty":-7.119431,"marketCap":2086642686},{"date":"2023-06-02","current":-30.34056,"twenty":-26.780985,"median":-13.659011,"eighty":-7.119431,"marketCap":2193470805},{"date":"2023-06-09","current":-34.234979,"twenty":-26.930727,"median":-13.659011,"eighty":-7.119431,"marketCap":2475017808},{"date":"2023-06-16","current":-31.01725,"twenty":-26.930727,"median":-13.659011,"eighty":-7.119431,"marketCap":2242392092},{"date":"2023-06-23","current":-30.10579,"twenty":-26.891574,"median":-13.647797,"eighty":-7.11651,"marketCap":2176498113},{"date":"2023-06-30","current":-21.571213,"twenty":-26.72914,"median":-13.636582,"eighty":-7.11359,"marketCap":1559490850},{"date":"2023-07-07","current":-22.082183,"twenty":-26.566581,"median":-13.636582,"eighty":-7.11359,"marketCap":1596431414},{"date":"2023-07-14","current":-21.736933,"twenty":-26.246081,"median":-13.636582,"eighty":-7.11359,"marketCap":1571471573},{"date":"2023-07-21","current":-20.991193,"twenty":-26.032581,"median":-13.636582,"eighty":-7.11359,"marketCap":1517558317},{"date":"2023-07-28","current":-18.510356,"twenty":-25.900267,"median":-13.636582,"eighty":-7.11359,"marketCap":1371395231},{"date":"2023-08-04","current":-18.226827,"twenty":-25.725158,"median":-13.636582,"eighty":-7.11359,"marketCap":1350389178},{"date":"2023-08-11","current":-20.090014,"twenty":-25.632931,"median":-13.636582,"eighty":-7.11359,"marketCap":1488428960},{"date":"2023-08-18","current":-19.090914,"twenty":-25.535318,"median":-13.636582,"eighty":-7.11359,"marketCap":1414407627},{"date":"2023-08-25","current":-18.348339,"twenty":-25.35625,"median":-13.636582,"eighty":-7.11359,"marketCap":1359391772},{"date":"2023-09-01","current":-18.645369,"twenty":-25.270172,"median":-13.636582,"eighty":-7.11359,"marketCap":1381398114},{"date":"2023-09-08","current":-19.725477,"twenty":-25.104163,"median":-13.636582,"eighty":-7.11359,"marketCap":1461421177},{"date":"2023-09-15","current":-20.25203,"twenty":-24.980609,"median":-13.636582,"eighty":-7.11359,"marketCap":1500432420},{"date":"2023-09-22","current":-17.970302,"twenty":-24.737721,"median":-13.636582,"eighty":-7.11359,"marketCap":1331383700},{"date":"2023-09-29","current":-15.148519,"twenty":-24.618435,"median":-13.636582,"eighty":-7.11359,"marketCap":1122323450},{"date":"2023-10-06","current":-15.067511,"twenty":-24.500824,"median":-13.636582,"eighty":-7.11359,"marketCap":1116321720},{"date":"2023-10-13","current":-14.973001,"twenty":-24.433267,"median":-13.636582,"eighty":-7.11359,"marketCap":1109319702},{"date":"2023-10-20","current":-13.636367,"twenty":-24.347195,"median":-13.636367,"eighty":-7.11359,"marketCap":1010291162},{"date":"2023-10-27","current":-11.957845,"twenty":-24.235304,"median":-13.588437,"eighty":-7.10483,"marketCap":966779830},{"date":"2023-11-03","current":-12.100127,"twenty":-24.100234,"median":-13.537772,"eighty":-7.10483,"marketCap":978283160},{"date":"2023-11-10","current":-11.753702,"twenty":-23.899065,"median":-13.487141,"eighty":-7.10483,"marketCap":950275053},{"date":"2023-11-17","current":-13.028051,"twenty":-23.701223,"median":-13.463736,"eighty":-7.10483,"marketCap":1053304875},{"date":"2023-11-24","current":-15.193206,"twenty":-23.64083,"median":-13.463736,"eighty":-7.10483,"marketCap":1228355542},{"date":"2023-12-01","current":-15.118972,"twenty":-23.382093,"median":-13.463736,"eighty":-7.10483,"marketCap":1222353805},{"date":"2023-12-08","current":-22.319661,"twenty":-23.156555,"median":-13.470765,"eighty":-7.10775,"marketCap":1804522312},{"date":"2023-12-15","current":-23.779595,"twenty":-22.865343,"median":-13.470765,"eighty":-7.10775,"marketCap":1922556476},{"date":"2023-12-22","current":-22.282545,"twenty":-22.81441,"median":-13.470765,"eighty":-7.10775,"marketCap":1801521443},{"date":"2023-12-29","current":-23.841457,"twenty":-22.774551,"median":-13.463736,"eighty":-7.10483,"marketCap":1927557924},{"date":"2024-01-05","current":-22.987767,"twenty":-22.665451,"median":-13.456707,"eighty":-7.101909,"marketCap":1858537946},{"date":"2024-01-12","current":-26.018985,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2103608881},{"date":"2024-01-19","current":-25.907634,"twenty":-22.612622,"median":-13.445716,"eighty":-7.098989,"marketCap":2094606275},{"date":"2024-01-26","current":-26.612856,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2151622779},{"date":"2024-02-02","current":-29.631701,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2395693424},{"date":"2024-02-09","current":-33.798336,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":2903108113},{"date":"2024-02-16","current":-37.261233,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":3200553597},{"date":"2024-02-23","current":-41.718542,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":3583414168},{"date":"2024-03-01","current":-97.224678,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8351113716},{"date":"2024-03-08","current":-94.212301,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8092365608},{"date":"2024-03-15","current":-82.817705,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7113626794},{"date":"2024-03-22","current":-89.870896,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7719460652},{"date":"2024-03-28","current":-106.103421,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":9113753375},{"date":"2024-04-05","current":-93.804897,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":8057371594},{"date":"2024-04-12","current":-90.938346,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7811149234},{"date":"2024-04-19","current":-82.982684,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":7127797671},{"date":"2024-04-26","current":-81.018661,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7593068940},{"date":"2024-05-03","current":-89.136999,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8353919589},{"date":"2024-05-10","current":-94.360974,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":8843510442},{"date":"2024-05-17","current":-81.253975,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":7615122582},{"date":"2024-05-24","current":-72.441461,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6789213689},{"date":"2024-05-31","current":-72.68854,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6812370013},{"date":"2024-06-07","current":-64.723157,"twenty":-22.652761,"median":-13.463736,"eighty":-7.10483,"marketCap":6065854232},{"date":"2024-06-14","current":-61.299336,"twenty":-22.623067,"median":-13.456707,"eighty":-7.101909,"marketCap":5744973741},{"date":"2024-06-21","current":-59.334463,"twenty":-22.612622,"median":-13.445716,"eighty":-7.098989,"marketCap":5560825830},{"date":"2024-06-28","current":-59.734497,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":5598317021},{"date":"2024-07-05","current":-59.381525,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":5565236558},{"date":"2024-07-12","current":-68.982343,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":6465025152},{"date":"2024-07-15","current":-67.276315,"twenty":-22.547664,"median":-13.342177,"eighty":-7.096069,"marketCap":6305136247},{"date":"2024-08-02","current":-62.587341,"twenty":-22.095993,"median":-13.232948,"eighty":-7.052266,"marketCap":6055012330},{"date":"2024-08-09","current":-63.87001,"twenty":-22.443419,"median":-13.232948,"eighty":-7.052266,"marketCap":6179104074},{"date":"2024-08-16","current":-65.278654,"twenty":-22.56606,"median":-13.232948,"eighty":-7.052266,"marketCap":6315383400},{"date":"2024-08-23","current":-73.696165,"twenty":-22.69325,"median":-13.232948,"eighty":-7.052266,"marketCap":7129735470},{"date":"2024-08-30","current":-71.749258,"twenty":-22.870541,"median":-13.232948,"eighty":-7.052266,"marketCap":6941381930},{"date":"2024-09-06","current":-63.434819,"twenty":-23.27125,"median":-13.232948,"eighty":-7.052266,"marketCap":6137001518},{"date":"2024-09-13","current":-71.932496,"twenty":-23.507404,"median":-13.232948,"eighty":-7.052266,"marketCap":6959109322},{"date":"2024-09-20","current":-78.059528,"twenty":-23.680616,"median":-13.232948,"eighty":-7.052266,"marketCap":7551868992},{"date":"2024-09-27","current":-71.371329,"twenty":-23.823137,"median":-13.232948,"eighty":-7.052266,"marketCap":6904819184},{"date":"2024-10-04","current":-73.421307,"twenty":-24.072444,"median":-13.232948,"eighty":-7.052266,"marketCap":7103144382},{"date":"2024-10-11","current":-71.52021,"twenty":-24.313704,"median":-13.232948,"eighty":-7.052266,"marketCap":6919222690},{"date":"2024-10-18","current":-73.999653,"twenty":-24.497666,"median":-13.232948,"eighty":-7.052266,"marketCap":7159096463},{"date":"2024-10-25","current":-82.292383,"twenty":-24.926912,"median":-13.232948,"eighty":-7.052266,"marketCap":8159372036},{"date":"2024-10-31","current":-80.640241,"twenty":-25.54012,"median":-13.232948,"eighty":-7.052266,"marketCap":7995560552},{"date":"2024-11-08","current":-77.380914,"twenty":-26.452015,"median":-13.232867,"eighty":-7.025984,"marketCap":7672395038},{"date":"2024-11-15","current":-60.207634,"twenty":-26.619064,"median":-13.232867,"eighty":-7.025984,"marketCap":5969647090},{"date":"2024-11-22","current":-58.027256,"twenty":-26.775391,"median":-13.232867,"eighty":-7.025984,"marketCap":5753460505},{"date":"2024-11-29","current":-59.499573,"twenty":-27.978567,"median":-13.232867,"eighty":-7.025984,"marketCap":5899442168},{"date":"2024-12-06","current":-56.060421,"twenty":-28.427248,"median":-13.232867,"eighty":-7.025984,"marketCap":5558446833},{"date":"2024-12-13","current":-53.801371,"twenty":-28.890511,"median":-13.232867,"eighty":-7.025984,"marketCap":5334459702},{"date":"2024-12-20","current":-46.630852,"twenty":-29.221496,"median":-13.232867,"eighty":-7.025984,"marketCap":4623495572},{"date":"2024-12-27","current":-47.9683,"twenty":-29.590258,"median":-13.232867,"eighty":-7.025984,"marketCap":4756104869},{"date":"2025-01-03","current":-46.215007,"twenty":-29.679256,"median":-13.232867,"eighty":-7.025984,"marketCap":4582264110},{"date":"2025-01-10","current":-45.630575,"twenty":-30.111314,"median":-13.223191,"eighty":-6.999702,"marketCap":4524317190},{"date":"2025-01-17","current":-36.594373,"twenty":-30.341993,"median":-13.223191,"eighty":-6.999702,"marketCap":3628368663},{"date":"2025-01-24","current":-39.269269,"twenty":-30.456513,"median":-13.223191,"eighty":-6.999702,"marketCap":3893587256},{"date":"2025-01-31","current":-37.864386,"twenty":-31.008964,"median":-13.223191,"eighty":-6.999702,"marketCap":3754291776},{"date":"2025-02-07","current":-31.920763,"twenty":-31.503362,"median":-13.223191,"eighty":-6.999702,"marketCap":3510102907},{"date":"2025-02-14","current":-29.932057,"twenty":-31.56965,"median":-13.223191,"eighty":-6.999702,"marketCap":3291418810},{"date":"2025-02-21","current":-32.093253,"twenty":-31.671844,"median":-13.223191,"eighty":-6.999702,"marketCap":3529070405},{"date":"2025-02-28","current":-29.089901,"twenty":-31.7768,"median":-13.223191,"eighty":-6.999702,"marketCap":3198812789},{"date":"2025-03-07","current":-29.275912,"twenty":-31.80442,"median":-13.213514,"eighty":-6.973421,"marketCap":3219267162},{"date":"2025-03-14","current":-30.347729,"twenty":-31.80442,"median":-13.23303,"eighty":-6.973421,"marketCap":3337127361},{"date":"2025-03-21","current":-28.939056,"twenty":-31.80442,"median":-13.308111,"eighty":-6.973421,"marketCap":3182225385},{"date":"2025-03-28","current":-26.672929,"twenty":-31.80442,"median":-13.470765,"eighty":-6.973421,"marketCap":2933035249},{"date":"2025-04-04","current":-24.723243,"twenty":-31.80442,"median":-13.524439,"eighty":-6.973421,"marketCap":2718641933},{"date":"2025-04-11","current":-21.967142,"twenty":-31.7768,"median":-13.537772,"eighty":-6.999702,"marketCap":2415572849},{"date":"2025-04-17","current":-24.09036,"twenty":-31.7768,"median":-13.537772,"eighty":-6.999702,"marketCap":2649048292}],"updateTime":1745233568622}}}